As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?

As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?

As a pioneer in the field of extracorporeal photopheresis (ECP) can you provide some background and history on how this therapeutic strategy was developed and for what challenging conditions, in particular, in CTCL?


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Richard Edelson, MD

Richard Edelson, MD

Aaron B. and Marguerite Lerner Professor of Dermatology
Chair and Professor
Department of Dermatology
Yale School of Medicine